Skip to main content
Mobile dropdown close
More coming soon
DSCSA: Explore these additional resources
1 - 10 of 119 Displaying Results
2016 Global Drug Supply, Safety and Traceability Report
See how 331 life sciences companies are faring with DSCSA lot-level requirements and serialization readiness.
Excellis Q&A: Why Phase 3 Manufacturers Shouldn’t Delay Serialization
See how Excellis Health Solutions avoids bottlenecks in serialization implementation, DSCSA challenges, and their philosophy behind phase 3 planning.
6-Minute Webinar: Serialization Readiness for Hospitals and Pharmacies
Get started on serialization with this on-demand webinar that reviews DSCSA requirements for hospitals and why to begin preparing now.
Digital Information Sharing: Master Data and Verification
Easily share master data with your trading partners and enable DSCSA saleable returns verification with TraceLink's digital sharing platform.
Phase 3 Planning: Serialization from the Sharp Packaging Perspective
If you're a Phase 3 pharma company, serialization will be part of your strategy. Watch Sharp SVPs discuss how they approach serialization.
An Open Letter from TraceLink’s CEO on the DSCSA Saleable Returns Enforcement Discretion
Read the letter from TraceLink CEO Shabbir Dahod on the FDA announcement on DSCSA verification requirement for saleable returns.
Solving Saleable Returns: Critical Steps Toward Meeting the Deadline
In this webinar series, TraceLink experts will guide you through the maze of saleable returns and product verification:
Why Phase 3 Flexion Therapeutics Seized On Serialization Early
Hear how addressing serialization well before your PDUFA date minimizes risk to your commercial launch.
DSCSA Saleable Returns: Critical 2019 Decisions for India Manufacturers
Watch this webinar series to learn how India manufacturers should prepare for DSCSA saleable returns with live Q&A in Hindi and English.
A Day in the Life of a Serial Number
With the DSCSA serialization deadline looming, get a bird’s eye view into the life of a serial number as it travels through the pharmaceutical supply…